Theravance Biopharma, Inc.·4

May 22, 6:06 PM ET

HAUMANN BRETT K 4

4 · Theravance Biopharma, Inc. · Filed May 22, 2020

Insider Transaction Report

Form 4
Period: 2020-05-20
HAUMANN BRETT K
SVP, Clinical Development
Transactions
  • Tax Payment

    Ordinary Shares

    2020-05-20$26.67/sh4,212$112,334312,456 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -